Southern African Journal of HIV Medicine
ISSN: (Online) 2078-6751, (Print) 1608-9693
http://www.sajhivmed.org.za
Published: 23 May 2018
For children orphaned or made vulnerable by HIV (OVC)
Poverty, HIV and other disease burdens, coupled with common mental disorders including alcohol and other substance use disorders, posttraumatic stress disorder, clinical and postnatal depression, distress, and anxiety, impact how caregivers meet the needs of children. When mental health is not consi...dered or addressed, there can be a significant impact on an individual, their family and the community.
more
The Global Early Warning – Early Action (EWEA) report on food security and agriculture is developed by the Food and Agriculture Organization of the United Nations (FAO). The report is part of FAO’s EWEA system, which aims to translate forecasts and early warnings into anticipatory action.
L’Agenda pour l’action contre l’exploitation sexuelle des enfants à des fins commerciales fournit un cadre détaillé et établit des catégories d’actions devant être prises par les gouvernements en partenariat
avec les organisations de la société civile et les autres acteurs-clés pou...r combattre les crimes sexuels
de nature commerciale commis contre les enfants. De manière générale, ces actions se concentrent
sur 1) la Coordination et la Coopération, 2) la Prévention, 3) la Protection, 4) le Rétablissement et la
Réinsertion et 5) la Participation des enfants.
more
treat TB
Description of Research Outputs, 2009 - 2014
This Training Manual is developed based on the Child Protection Working Group Interagency Guidelines for Case Management. The Facilitator’s Guide provides guidance on the key steps to take before, during and after training, including customizing the training to different contexts and audiences.
IAEA Safety Standards for protecting people and the environment
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)... has decreased TB incidence of people living with HIV/AIDS. They are comprehensive, giving an overview of the range of activities that could be undertaken in high burden TB/HIV countries or where a rising prevalence of HIV might fuel TB. Activities highlight the need for comprehensive care, prevention and support for adults living with HIV/AIDS. Comprehensive TB and HIV care and prevention rely on full implementation of the DOTS strategy as part of a wide ranging HIV/AIDS care and prevention programme as well as collaborative TB and HIV programme activities.
more
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is... intended to be used a practical guide for policymakers and program
managers wishing to develop or strengthen a CHW program, drawing lessons from other countries that have implemented CHW programs at-scale. Throughout, we discuss major policy and programmatic issues that decision-makers and planners need to consider when designing, implementing, scaling up or strengthening a national-level CHW program. We offer an overview
of specific challenges CHW programs face, country lessons, tools, and other resources that may be helpful, while incorporating relevant programmatic examples as much as possible.
more
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...tious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
more
16-17 march 2015, Geneva, Switzerland
Meeting report